RNA Structure and its Potential Therapeutics (G106480549)

Target Name: RNU4-76P

NCBI ID: G106480549

RNU4-76P

Other Name(s): RNA, U4 small nuclear 76, pseudogene

RNA Structure and its Potential Therapeutics

RNA, U4 small nuclear 76 (RNU4-76P), is a molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments.

The RNA molecule is named after its position in the DNA sequence, it is located on the 76th position. It is a small molecule that plays a vital role in the regulation of gene expression, it is a key player in the development and maintenance of cellular RNA fractions. RNU4-76P is a transcribed RNA molecule that contains 76 base pairs of RNA. It is a small RNA molecule that contains a unique structure, composed of four regions: an 5' end, a 3' end, a stem-loop region, and a loop region.

One of the key features of RNU4-76P is its shape. It has a unique 3D structure, with a long tail that reaches the 5' end, a stem-loop region in the middle, and a 3' end that is composed of a double-stranded loop. This shape allows it to interact with other molecules in the cell, including proteins, which can help to regulate its function.

RNA molecules are constantly being produced and degraded in the cell, but the levels of some RNA molecules can remain stable and be used as a template for protein synthesis. RNU4-76P is one of these RNA molecules that can be used as a template for protein synthesis, it has been shown to have a strong association with protein synthesis and can be used as a protein biomarker.

In neurodegenerative diseases, RNA molecules are often alterated, and this can lead to the misfolding of proteins and the formation of aberrant proteins that are harmful to the brain. RNU4-76P has been shown to be involved in the regulation of neurodegenerative diseases, it has been shown to play a role in the development of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential role in neurodegenerative diseases, RNU4-76P has also been shown to be involved in cancer. Cancer is a disease that is characterized by the formation of tumors, and the regulation of RNA molecules is a key aspect of tumor development. RNU4-76P has been shown to play a role in the regulation of cancer cell growth and has been used as a potential biomarker for cancer.

In conclusion, RNU4-76P is a small RNA molecule that has unique structure and biology, it is involved in the regulation of gene expression and has been shown to play a role in various diseases, including cancer and neurodegenerative diseases. Its potential as a drug target or biomarker makes it an attractive target for researchers to study and develop new treatments. Further studies are needed to fully understand its role in these diseases and to determine its potential as a drug.

Protein Name: RNA, U4 Small Nuclear 76, Pseudogene

The "RNU4-76P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4-76P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets